University of Groningen
Insight in the brain
Larabi, Daouia
DOI:
10.33612/diss.118152005
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Larabi, D. (2020). Insight in the brain: a multimodal approach investigating insight in individuals with a
psychotic disorder and healthy individuals. University of Groningen.
https://doi.org/10.33612/diss.118152005
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
Propositions belonging to the PhD thesis
INSIGHT IN THE BRAIN
A multimodal approach investigating insight in individuals
with a psychotic disorder and healthy individuals
By Daouia I. Larabi
1.
Impaired clinical insight is associated with spatially diffuse abnormalities across the brain in patients with a psychotic disorder, suggesting such insight requires a broad range of cognitive functions that necessitate global brain integration (Chapter 2).2.
Lower concentrations of dorsolateral prefrontal N-acetylaspartate, and by inference lower dorsolateral prefrontal neuronal integrity, is related to lower scores on the clinical insight subdimension “awareness of illness” in patients with a psychotic disorder (Chapter 3).3.
Patients with schizophrenia and a poorer ability to relabel symptoms engage differentneural pathways during the expressive suppression of negative emotions, which are implicated in cognitive-emotional control and visual processing of negative stimuli (Chapter 4).
4.
System-level abnormalities in schizophrenia-spectrum disorders appear to have meaning for specific symptomatology given that a lower ability to attribute symptoms to the illness (i.e. contributing to lower clinical insight) is related to higher betweenness centrality and decreased segregation of the gray matter connectome into separate subnetworks(Chapter 5).